AbbVie
NYSE:ABBV
$ 200,50
$-4,62 (-2,25%)
200,50 $
$-4,62 (-2,25%)
End-of-day quote: 04/22/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

G
2,49%
5-year Growth Rate
R
4/6
5-year Risk Analysis
O
25,40%
Outlook 12/26
W
-24,74%
Margin of safety
T
26,43%
Analyst Price Target
H
DOWN
50-week EMA Trend

Company Info

EPS Growth 5Y
-1,08%
Revenue growth 5Y
5,94%
Price growth 5Y
82,19%
Market Cap
$354,64 B
Long-Term Debt
$60,32 B
Short Interest
2,67%
Quarterly earnings
04/29/2026
Dividend
$6,76
Dividend Yield
3,37%
Industry
ISIN Number

AbbVie Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$253,50
26.43%
26.43
Last Update: 04/23/2026
Analysts: 29

Highest Price Target $294,00

Average Price Target $253,50

Lowest Price Target $184,00

Top growth stocks in the health care sector

Stock Rate of Return 5Y Price 5Y Div. 5Y G R O W T H
AbbVie
NYSE:ABBV
109,40% 82,19% 27,21% 2,49% 4/6 25,40% -24,74% 26,43% DOWN
×